NEW YORK, Sept. 16, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Nuclear Medicine Imaging Equipment in US$ Million by the following Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and PET Scanners (Includes PET and PET/CT systems). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 31 companies including many key and niche players such as - Digirad Corp.GE Healthcare PlcMediso Medical Imaging SystemsPhilips HealthcarePositron CorporationRead the full report: http://www.reportlinker.com/p02365016-summary/view-report.htmlI. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Single-Photon Emission Computed Tomography (SPECT) Systems I-3SPECT/CT Systems I-4PET Scanners I-4PET/CT Systems I-4II. EXECUTIVE SUMMARY1. INDUSTRY OVERVIEW AND OUTLOOK II-1Nuclear Medicine Imaging Equipment - A Prelude II-1Impact of Recession on the Nuclear Medicine Market: In Retrospect II-2The Road to Recovery II-2Impact of Healthcare Budget Cuts in Developed Economies: A Review II-2Positive Outlook for the Healthcare Industry Signals Growth II-3Table 1: Healthcare Spending as a Percentage of GDP in SelectDeveloped Countries (includes corresponding Graph/Chart) II-4US - The Dominant Market II-5Table 2: US Cancer Incidence by Gender: 2014E (includescorresponding Graph/Chart) II-5Developing Nations Offer Lucrative Opportunities II-5Table 3: Healthcare Spending as a Percentage of GDP in SelectDeveloping Countries - Lower Share Promising Potential: 2012(includes corresponding Graph/Chart) II-6Personalized Medicine Slowly Gaining Ground II-6Table 4: Drug Ineffectiveness for Select TherapeuticCategories as a Percentage of Patient Population (includescorresponding Graph/Chart) II-6Rising Incidence of Cancer - A Major Growth Driver II-8World Cancer Statistics - Incidence and Mortality Data II-8Table 5: World Cancer Incidence by Geographic Region (2012):Number of New Cancer Cases Reported in Thousands forAsia-Oceania, Europe, North America, Latin America & theCaribbean, and Africa (includes corresponding Graph/Chart) II-8Table 6: World Cancer Mortality by Geographic Region andGender (2012): Number of Cancer-Related Deaths in Thousandsfor Asia-Oceania, Europe, North America, Latin America & theCaribbean, and Africa (includes corresponding Graph/Chart) II-9Table 7: Global Incidence of Common Cancers in Men (2012):Number of New Cases Reported in Thousands for Lung &Bronchus, Prostate, Colorectal and Liver Cancers (includescorresponding Graph/Chart) II-9Table 8: Global Incidence of Common Cancers in Women (2012):Number of New Cases Reported in Thousands for Breast,Colorectal, Lung & Bronchus and Liver Cancers (includescorresponding Graph/Chart) II-10Table 9: Global Cancer Mortality in Men for Select Cancers(2012): Number of Deaths in Thousands for Lung & Bronchus,Liver, Colorectal and Prostate Cancers (includescorresponding Graph/Chart) II-10Table 10: Global Cancer Mortality in Women for SelectCancers (2012): Number of Deaths in Thousands for Breast,Lung & Bronchus, Colorectal and Liver (includescorresponding Graph/Chart) II-10Table 11: World Breast Cancer Statistics: Top 20 Countrieswith Highest Breast Cancer Rates (includes correspondingGraph/Chart) II-11Cancer Prone Sites based on Age II-11Table 12: Cancer Incidence in Developed Nations By Site:2012 (includes corresponding Graph/Chart) II-12Software Developments Improve Nuclear Medicine Imaging II-12Competitive Landscape II-13Competitive Overview in Nuclear Medicine Market II-13Table 13: Global SPECT Systems (Gamma Cameras) Market byLeading Player (2013): Percentage Market Share Breakdown ofValue Sales for GE, Philips, Siemens, and Others (includescorresponding Graph/Chart) II-13Table 14: Global PET Scanner Market by Leading Player(2013): Percentage Market Share Breakdown of Value Sales forGE, Philips, Siemens, and Others (includes correspondingGraph/Chart) II-13A Completive Analysis of Major Players in the NuclearMedicine Market II-142. MARKET TRENDS AND ISSUES II-15Hybrid Imaging to Herald a New Era of Diagnosis II-15Duration of Hybrid Imaging Procedure Bodes Well for Market II-15Major Players Come Up with New Hybrid PET/MRI Systems II-16Broad Clinical Applications to Drive Demand for Hybrid PET/MRSystems II-16Digital Silicon Photomultiplier Array for PET/MRI Systems II-17PET-MRI Emerging as a Promising Standard for Imaging SoftTissue Contrast II-17Technology Innovations Promise Bright Prospects II-17Technological Advancements to Drive Growth II-18Advances in Software II-18Iterative Reconstruction II-18Resolution Recovery II-18Noise Compensation II-19Hardware Developments II-19Solid-State Detectors II-19Innovative Radiopharmaceuticals to Boost Cardiac Applications II-19Global CVD Stats II-20Table 15: Global Estimated Fatalities by Heart Conditions -Percentage Share Breakdown for Ischemic Heart Disease,Stroke, CVD, and Others (includes corresponding Graph/Chart) II-20Table 16: Projected Fatalities in Low Income Countries byDisease (2015 & 2030): Percentage Share Breakdown of Numberof Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;Malnutrition; and Others (includes correspondingGraph/Chart) II-21Table 17: Projected Fatalities in Mid Income Countries byDisease (2015 & 2030): Percentage Share Breakdown of Numberof Deaths for CVD; Cancer; Injury; HIV, TB & Malaria;Malnutrition; and Others (includes correspondingGraph/Chart) II-21Table 18: Projected Fatalities in High Income Countries byDisease (2015 & 2030): Percentage Share Breakdown of Numberof Deaths for CVD, Cancer, Injury and Others (includescorresponding Graph/Chart) II-22Table 19: Estimated Annual Medical Cost (US$ Billions) forCoronary Heart Disease (2015, 2020 & 2025) (includescorresponding Graph/Chart) II-22Battling Alzheimer's Disease - A Powerful Market Force forNuclear Medicine II-22Hypoxia Imaging - The Future of Cancer Therapy II-23PET or SPECT for Cardiac Imaging - The Debate Continues II-23Table 20: Worldwide Installed Base of Nuclear Imaging Devicesby Modality (2013) Percentage Share Breakdown of Number ofInstallations for SPECT and PET (includes correspondingGraph/Chart) II-24Global Nuclear Medicine Market - A Historic Perspective Builder II-24Table 21: Global Gamma Cameras (SPECT) Market (2006):Installed Base in Units by Select Country - USA, Japan,Canada, and UK (includes corresponding Graph/Chart) II-24Table 22: Global PET Scanners Market (2006): Installed Basein Units by Select Country - USA, Europe, Japan, Germany,Canada, UK, France, Italy, and Belgium (includescorresponding Graph/Chart) II-25Innovative Radiotracers - Key to PET & SPECT Success II-25Innovative Biomarkers to Extend PET in Oncology II-26Application of PET in Drug Development to Expand Opportunities II-26SPECT Innovations to Improve Efficiency II-27Cardiocentric SPECT II-27Cardio-Focused Collimation II-28Mobile Devices - Future of Diagnostic Imaging? II-28Growing Smartphone Sales - A Business Case II-28Table 23: World Market for Smartphones (2011, 2013 & 2017P):Breakdown of Sales in Thousand Units by GeographicRegion/Country (includes corresponding Graph/Chart) II-29Global Technetium Shortage Eased II-29Ageing Population - A Vital Demography II-30Table 24: Global Population Statistics for the 65+ Age Group(Male & Female) for Major Countries/Regions: 2013E (includescorresponding Graph/Chart) II-31Table 25: Percentage of Population Aged 65 and Above inEurope, US, and Japan (1960-2030) (includes correspondingGraph/Chart) II-32Table 26: Elderly Population (65+ Years) as a Percentage ofthe Total Population: 2025 (includes correspondingGraph/Chart) II-32PET Eats its Way into Conventional Gamma Camera Market II-32Factors Restricting Market Growth II-33High Costs - A Major Threat for Market Growth II-33Supply Shortages: A Niggling Cause of Concern II-33Canadian Scientists Discover Means to Address Supply Shortages II-34Price Sensitivity & Competition from Alternatives LimitMarket Potential II-34Unfounded Fears of Radiation Exposure Hinder Growth II-35Bottlenecks in Developing Markets II-353. GLOBAL MEDICAL IMAGING MARKET - AN OVERVIEW II-36Medical Imaging - Changing the Landscape of Clinical Diagnosis II-36Image-Guided Interventions - Driving Growth in NuclearMedicine Arena II-36Understanding the Concept II-36Tremendous Market Potential II-36Clinical Application Areas II-36Diagnostic Imaging Witnesses Dramatic Growth II-37Table 27: Global Medical Imaging Equipment Installed Base(2013): Percentage Share Breakdown of Volume Installationsfor X-ray, Ultrasound, Magnetic Resonance, ComputedTomography, and Nuclear Medicine/PET by Country/Region(includes corresponding Graph/Chart) II-38Comparison of Modalities by Various Imaging Systems II-38Medical Imaging Equipment Manufacturers Fine Tune Technologies II-39Future Growth Prospects for Medical Imaging Equipment Market II-39Multiple Factors Support Global MRI Equipment Market Growth II-39Reimbursement Remains the Core Issue II-404. CANCER - A GLOBAL CONCERN II-41Cancer Incidence - Statistics on New Cases II-41Cancer Incidence in Developing Countries II-41Cancer in Asia II-42Cancer Cases - Mortality Rates II-425. NUCLEAR MEDICINE - AN INSIGHT II-43Distinct from General Radiology II-43History II-43Major Developments II-44Nuclear Medicine Scans II-44Bone Scan II-45Brain Scan II-45Gallbladder Scan II-45Kidney Scan II-46Liver Scan II-46Lung Scan II-46Thyroid Scan II-46Scrotal Scan II-47Applications II-47Cardiac Applications II-47Neurologic Applications II-47Oncologic Applications II-47Orthopedic Applications II-48Pulmonary Applications II-48Renal Applications II-48Other Applications II-48Table 28: Estimated Time Allocations for Nuclear MedicineProcedures II-49Radioisotopes: Essential for Nuclear Medicine Procedure II-49Radioisotopes Used in Medicine II-50Clinical Applications of Select Isotopes II-51Radionuclides in Nuclear Medicine Procedures II-52Table 29: Positron-Emitting Radionuclides in PET Procedures II-536. NUCLEAR MEDICINE IMAGING EQUIPMENT II-54Single-Photon Emission Computed Tomography (SPECT) Systems II-54SPECT/CT Systems II-54Positron Emission Tomography (PET) Scanners II-55Factors Influencing Growth of PET Scanners II-55PET/CT Systems II-55PET & Other Imaging Modalities II-56PET provides the following advantages over other imagingprocedures: II-56Table 30: Comparison of PET and Conventional ImagingTechniques (includes corresponding Graph/Chart) II-57Brain Imaging II-57Alzheimer's Disease II-58Brain Trauma II-58Epilepsy II-58Heart Imaging II-58Parkinson's Disease II-58Cancer II-58PET-CT: An Advancement in Cancer Diagnosis & Treatment II-59Mobile PET II-597. RESEARCH AND DEVELOPMENT IN THE RECENT PAST II-60Researchers Develop Portable PET Scanner, SynchroPET II-60Philips and University Medical Center Hamburg-EppendorfDevelop MRI/PET Imaging Tool II-60Indian Scientists Develop Low-Cost Nuclear Medicine Kit II-608. PRODUCT INNOVATIONS/INTRODUCTIONS II-61Philips Introduces Vereos Digital PET/CT II-61Siemens Unveils Biograph mCT Flow II-61MR Solutions to Unveil Revolutionary 3T, MR/PET Combined Scanner II-61DDD Obtains FDA Approval for CorCam™ II-61Digirad Introduces Imaging Accessory for Molecular Breast Imaging II-61GE Unveils Discovery PET/CT 610 and Q. Suite II-61Agfa Healthcare to Introduce Upgraded Version of IMPAX II-62GE Secures FDA Clearance for Brivio NM615 II-629. RECENT INDUSTRY ACTIVITY II-63AAA Takes Over UK-based Nuclear Medicine Company II-63BC Technical Inc Acquires NC Systems II-63BC Technical Acquires Xpert II-63GE Healthcare Acquires Orbotech Medical Solutions II-63Comecer Acquires Veenstra Instruments II-63GE Healthcare Collaborates with NXT2B II-63Zecotek Inks Development Deal with NuCare II-64Siemens Healthcare receives FDA Clearance for Biograph mCT PETCT Scanner II-64GE Healthcare Receives US FDA Clearance for Brivo NM615 GammaCamera II-6410. FOCUS ON SELECT GLOBAL PLAYER II-65Digirad Corp. (US) II-65GE Healthcare Plc (UK) II-65Mediso Medical Imaging Systems (Hungary) II-66Philips Healthcare (US) II-66Positron Corporation (US) II-66Siemens Healthcare (Germany) II-6711. GLOBAL MARKET PERSPECTIVE II-68Table 31: World Recent Past, Current & Future Analysis forNuclear Medicine Imaging Equipment by Geographic Region - US,Canada, Japan, Europe, Asia-Pacific (excluding Japan), LatinAmerica and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2013 through2020 (includes corresponding Graph/Chart) II-68Table 32: World Historic Review for Nuclear Medicine ImagingEquipment by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2006 through 2012 (includescorresponding Graph/Chart) II-69Table 33: World 15-Year Perspective for Nuclear MedicineImaging Equipment by Geographic Region - Percentage Breakdownof Value Sales for US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World Markets forYears 2006, 2014, & 2020 (includes corresponding Graph/Chart) II-70Nuclear Medicine Imaging Equipment Market by Product Segment II-71Table 34: World Recent Past, Current & Future Analysis forSPECT Systems by Geographic Region - US, Canada, Japan,Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) II-71Table 35: World Historic Review for SPECT Systems byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2006 through 2012 (includes correspondingGraph/Chart) II-72Table 36: World 15-Year Perspective for SPECT Systems byGeographic Region - Percentage Breakdown of Value Sales forUS, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets for Years 2006, 2014, &2020 (includes corresponding Graph/Chart) II-73Table 37: World Recent Past, Current & Future Analysis for PETScanners by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific (excluding Japan), Latin America and Rest ofWorld Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) II-74Table 38: World Historic Review for PET Scanners by GeographicRegion - US, Canada, Japan, Europe, Asia-Pacific (excludingJapan), Latin America and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2006 through 2012 (includes corresponding Graph/Chart) II-75Table 39: World 15-Year Perspective for PET Scanners byGeographic Region - Percentage Breakdown of Value Sales forUS, Canada, Japan, Europe, Asia-Pacific (excluding Japan),Latin America and Rest of World Markets for Years 2006, 2014, &2020 (includes corresponding Graph/Chart) II-76III. MARKET1. THE UNITED STATES III-1A.Market Analysis III-1Current & Future Analysis III-1Market Snapshots III-1Nuclear Medicine Market Drivers and Constraints III-2Nuclear Medicine Market in the US Rebounds in 2011 III-2Demographic Changes Offer Growth Opportunities III-2Table 40: North American Aging Population by Age Group:1975-2050 (includes corresponding Graph/Chart) III-3Therapeutic Applications to Drive Growth in the US NuclearMedicine Market III-3Market Witnesses Entry of High Value Products III-4Adoption of SPECT/CT Increasing in the US III-4PET Procedures in the US Increase III-4Nuclear Cardiology: Primary Growth Propellant III-5Dedicated Cardiac PET - The Future of Cardiac Imaging III-5Personalized Medicine - A Major Driver III-5Rising Incidence of Cancer - A Major Growth Driver III-6Table 41: US Cancer Fatalities by Gender (2014): PercentageShare Breakdown of No. of Deaths for Men and Women(includes corresponding Graph/Chart) III-6Table 42: New Cancer Cases by Gender and Affected Site inthe US (2013) III-7Managing Alzheimer's Opens New Avenues for PET/SPECT III-8Alzheimer's Stats III-8Table 43: Alzheimer's Prevalence in the US: As aPercentage of Population by Age-Group (includescorresponding Graph/Chart) III-8Table 44: Alzheimer's Prevalence in the US by State: 2014 &2025 (includes corresponding Graph/Chart) III-9Expanding Applications of Radiopharmaceuticals to StimulateGrowth III-10Table 45: Usage of Radiopharmaceutical Agents by NuclearMedicine Imaging Procedure in the US (2012): PercentageShare Breakdown of Procedure Volume by Type - SPECT and PET(includes corresponding Graph/Chart) III-10Table 46: US Market for Radiopharmaceuticals Agents byApplication (2012): Percentage Share Breakdown of ValueSales for Cardiology and Non-Cardiology Applications(includes corresponding Graph/Chart) III-10Isotope Shortage Leads to Dependence on Imports III-10DOE's Flawed Isotope Program Adds to the Woe III-11US Fluorodeoxyglucose (FDG) Market III-11Table 47: US FDG Market by Procedure Type (2012):Percentage Share Breakdown of Procedure Volume forOncology, Neurology, and Cardiology (includes correspondingGraph/Chart) III-11Nuclear Medicine Provision Industry Gradually Moves towardsConsolidation III-12Medical Imaging and Nuclear Medicine III-12Table 48: US Medical Imaging Market by Modality (2013):Percentage Share Breakdown of Revenues for ComputedTomography Imaging, Contrast Agent and Injector, MRI,Nuclear Medicine, Ultrasound Imaging and X-Ray Imaging(includes corresponding Graph/Chart) III-12Competition III-13Gamma Cameras III-13Table 49: US Gamma Camera Market by Leading Players(2013): Percentage Share Breakdown of Value Sales forDigirad Corporation, GE Healthcare, Philips Healthcare,Siemens Healthcare and Others (includes correspondingGraph/Chart) III-13Table 50: The US Gamma Camera Market in CardiologyApplication by Leading Player (2013): Percentage ShareBreakdown of Value Sales for Digirad Corporation, GEHealthcare, Philips Healthcare and Siemens Healthcare(includes corresponding Graph/Chart) III-13PET Scanners III-13Table 51: US PET Market by Leading Players (2013):Percentage Market Share Breakdown of Value Sales for GEHealthcare, Philips Healthcare, Siemens Healthcare andOthers (includes corresponding Graph/Chart) III-14Regulatory Overview III-14Nuclear Regulatory Commission (NRC) III-14Food and Drug Administration (FDA) III-14Environmental Protection Agency (EPA) III-14Centers for Medicare & Medicaid Services (CMS) III-15Overview of Medicare Reimbursements III-15Medicare Payment Settings for Contrast Agents andRadiopharmaceuticals III-15Medicare Coverage III-15Product Launches III-16Strategic Corporate Development III-16Select Key Players III-17B.Market Analytics III-19Table 52: The US Recent Past, Current & Future Analysis forNuclear Medicine Imaging Equipment by Product Segment -SPECT Systems (with Single Head Gamma Cameras, Dual HeadGamma Cameras, and Triple Head Gamma Cameras) and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2013 through 2020(includes corresponding Graph/Chart) III-19Table 53: The US Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems (withSingle Head Gamma Cameras, Dual Head Gamma Cameras, andTriple Head Gamma Cameras) and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2006 through 2012 (includescorresponding Graph/Chart) III-20Table 54: The US 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems (with Single Head GammaCameras, Dual Head Gamma Cameras, and Triple Head GammaCameras) and PET Scanners Markets for Years 2006, 2014, &2020 (includes corresponding Graph/Chart) III-212. CANADA III-22A.Market Analysis III-22Current & Future Analysis III-22Canada Faces Paucity of PET Scanners III-22PET Imaging for Cancer - A Long Way to Go III-22Canadian Scientists Discover Remedy for Isotope Shortages III-23An Overview of Medical Imaging Market III-23Regulatory and Legal Restrictions III-24Product Launch III-24B.Market Analytics III-25Table 55: Canadian Recent Past, Current & Future Analysisfor Nuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-25Table 56: Canadian Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-26Table 57: Canadian 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-273. JAPAN III-28A.Market Analysis III-28Japanese Healthcare System: An Overview III-28Fast Facts III-28Demographics Drive Market Growth III-28Table 58: Japanese Population by Age Group (2012) (includescorresponding Graph/Chart) III-28Table 59: Japanese 65+ Years Population: 1950-2010(includes corresponding Graph/Chart) III-29Market Scenario III-29Table 60: PET Studies Performed in Japan (2008): PercentageBreakdown by Type - Tumor, Brain, Heart, and Others(includes corresponding Graph/Chart) III-29Production and Exports of Nuclear medicine imaging equipmentSuffer in Japan III-30Reimbursement Issues III-30Government Initiatives III-30B.Market Analytics III-31Table 61: Japanese Recent Past, Current & Future Analysisfor Nuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-31Table 62: Japanese Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-32Table 63: Japanese 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-334. EUROPE III-34A.Market Analysis III-34Debt Crisis in Europe Affects Healthcare Industry III-34European Healthcare System: In a State of Transition? III-34Table 64: European Installed Base for Diagnostic ImagingEquipment by Modality (2013): Percentage Share Breakdown ofVolume Installations for SPECT, PET/CT, SPECT/CT, Planar,Cardiac SPECT, and PET/MR (includes correspondingGraph/Chart) III-35Oncology Dominates Nuclear Medicine Procedure III-35Table 65: Cancer Incidence in Europe by Site: 2012 (inThousands) (includes corresponding Graph/Chart) III-36Table 66: European Nuclear Medicine Market by TherapeuticArea: Percentage Share Breakdown of Imaging Volume forOncology, Cardiac, Endocrine, Lung, Renal, Brain andInfection (includes corresponding Graph/Chart) III-37Ageing Demography - An Opportunity Indicator III-37Table 67: Population Breakup by Age Group for SelectEuropean Countries: 2011 (as a Percentage of TotalPopulation) (includes corresponding Graph/Chart) III-38B.Market Analytics III-39Table 68: European Recent Past, Current & Future Analysisfor Nuclear Medicine Imaging Equipment by Geographic Region -France, Germany, Italy, UK, Spain, Russia and Rest ofEurope Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2013 through 2020(includes corresponding Graph/Chart) III-39Table 69: European Historic Review for Nuclear MedicineImaging Equipment by Geographic Region - France, Germany,Italy, UK, Spain, Russia and Rest of Europe MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2006 through 2012 (includescorresponding Graph/Chart) III-40Table 70: European 15-Year Perspective for Nuclear MedicineImaging Equipment by Geographic Region - PercentageBreakdown of Value Sales for France, Germany, Italy, UK,Spain, Russia and Rest of Europe Markets for Years 2006,2014, & 2020 (includes corresponding Graph/Chart) III-41Table 71: European Recent Past, Current & Future Analysisfor Nuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-42Table 72: European Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-43Table 73: European 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-444a. FRANCE III-45Market Analysis III-45Table 74: French Recent Past, Current & Future Analysis forNuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-45Table 75: French Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-46Table 76: French 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-474b. GERMANY III-48Market Analysis III-48Table 77: German Recent Past, Current & Future Analysis forNuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-48Table 78: German Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-49Table 79: German 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-504c. ITALY III-51A.Market Analysis III-51Current & Future Analysis III-51Product Launch III-51B.Market Analytics III-52Table 80: Italian Recent Past, Current & Future Analysis forNuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-52Table 81: Italian Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-53Table 82: Italian 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-544d. THE UNITED KINGDOM III-55A.Market Analysis III-55Current & Future Analysis III-55Strategic Corporate Development III-55Ge Healthcare Plc - A Key Player in The Uk III-55B.Market Analytics III-56Table 83: The UK Recent Past, Current & Future Analysis forNuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-56Table 84: The UK Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-57Table 85: The UK 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-584e. SPAIN III-59Market Analysis III-59Table 86: Spanish Recent Past, Current & Future Analysis forNuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-59Table 87: Spanish Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-60Table 88: Spanish 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-614f. RUSSIA III-62A.Market Analysis III-62Current & Future Analysis III-62B.Market Analytics III-62Table 89: Russian Recent Past, Current & Future Analysis forNuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-62Table 90: Russian Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-63Table 91: Russian 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-644g. REST OF EUROPE III-65A.Market Analysis III-65Current & Future Analysis III-65Mediso Medical Imaging Systems (Hungary) - A Key Player III-65Strategic Corporate Development III-65B.Market Analytics III-66Table 92: Rest of European Recent Past, Current & FutureAnalysis for Nuclear Medicine Imaging Equipment by ProductSegment - SPECT Systems and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-66Table 93: Rest of Europe Historic Review for NuclearMedicine Imaging Equipment by Product Segment - SPECTSystems and PET Scanners Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2006 through2012 (includes corresponding Graph/Chart) III-67Table 94: Rest of Europe 15-Year Perspective for NuclearMedicine Imaging Equipment by Product Segment - PercentageBreakdown of Value Sales for SPECT Systems and PET ScannersMarkets for Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-685. ASIA-PACIFIC III-69A.Market Analysis III-69Current & Future Analysis III-69Burden of Chronic Diseases in Aging Populace - PotentialOpportunities for Nuclear Medicine III-69Table 95: Over 65 Years Individuals as % of TotalPopulation in Select Asian Countries (includescorresponding Graph/Chart) III-70India & China Offer Significant Growth Opportunities III-71Table 96: China and India Leads Global Population (July2013): Table Depicting China and India's Huge PopulationVis-a-vis Other Countries' Population (in Million) by AgeGroup (includes corresponding Graph/Chart) III-71Table 97: Age-wise Breakup of China and India's PopulationVis-ŕ-vis Other Populous Countries Globally: As of July2013 (includes corresponding Graph/Chart) III-72B.Market Analytics III-73Table 98: Asia-Pacific Recent Past, Current & FutureAnalysis for Nuclear Medicine Imaging Equipment byGeographic Region - China, India and Rest of Asia-PacificMarkets Independently Analyzed with Annual Sales Figures inUS$ Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-73Table 99: Asia-Pacific Historic Review for Nuclear MedicineImaging Equipment by Geographic Region - China, India andRest of Asia-Pacific Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2006 through2012 (includes corresponding Graph/Chart) III-74Table 100: Asia-Pacific 15-Year Perspective for NuclearMedicine Imaging Equipment by Geographic Region - PercentageBreakdown of Value Sales for China, India and Rest ofAsia-Pacific Markets for Years 2006, 2014, & 2020 (includescorresponding Graph/Chart) III-75Table 101: Asia-Pacific Recent Past, Current & FutureAnalysis for Nuclear Medicine Imaging Equipment by ProductSegment - SPECT Systems and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-76Table 102: Asia-Pacific Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-77Table 103: Asia-Pacific 15-Year Perspective for NuclearMedicine Imaging Equipment by Product Segment - PercentageBreakdown of Value Sales for SPECT Systems and PET ScannersMarkets for Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-785a. CHINA III-79A.Market Analysis III-79Current & Future Analysis III-79Medical Imaging Device Market - An Overview III-79Increasing Expenditure on Healthcare Sector III-79B.Market Analytics III-80Table 104: Chinese Recent Past, Current & Future Analysisfor Nuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-80Table 105: Chinese Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-81Table 106: Chinese 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-825b. INDIA III-83A.Market Analysis III-83Current & Future Analysis III-83Table 107: Installed Base of Nuclear Medicine Scanners inIndia in 2011 (includes corresponding Graph/Chart) III-83India Offers High Growth Potential III-83Regulatory Mechanism for Guiding Isotope Production andDistribution III-84PET/CT Scanning in India Gathers Momentum III-84Overview of CT Scanners Market in India III-84Developments in Clinical Practice and Technology III-85Product Launch III-85B.Market Analytics III-86Table 108: Indian Recent Past, Current & Future Analysis forNuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-86Table 109: Indian Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-87Table 110: Indian 15-Year Perspective for Nuclear MedicineImaging Equipment by Product Segment - Percentage Breakdownof Value Sales for SPECT Systems and PET Scanners Marketsfor Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-885c. REST OF ASIA-PACIFIC III-89A.Market Analysis III-89Current & Future Analysis III-89Korea III-89Strategic Corporate Development III-89B.Market Analytics III-90Table 111: Rest of Asia-Pacific Recent Past, Current &Future Analysis for Nuclear Medicine Imaging Equipment byProduct Segment - SPECT Systems and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-90Table 112: Rest of Asia-Pacific Historic Review for NuclearMedicine Imaging Equipment by Product Segment - SPECTSystems and PET Scanners Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2006 through2012 (includes corresponding Graph/Chart) III-91Table 113: Rest of Asia-Pacific 15-Year Perspective forNuclear Medicine Imaging Equipment by Product Segment -Percentage Breakdown of Value Sales for SPECT Systems andPET Scanners Markets for Years 2006, 2014, & 2020 (includescorresponding Graph/Chart) III-926. LATIN AMERICA III-93A.Market Analysis III-93Current & Future Analysis III-93B.Market Analytics III-94Table 114: Latin American Recent Past, Current & FutureAnalysis for Nuclear Medicine Imaging Equipment byGeographic Region - Brazil and Rest of Latin America MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-94Table 115: Latin American Historic Review for NuclearMedicine Imaging Equipment by Geographic Region - Brazil andRest of Latin America Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2006 through2012 (includes corresponding Graph/Chart) III-95Table 116: Latin American 15-Year Perspective for NuclearMedicine Imaging Equipment by Geographic Region - PercentageBreakdown of Value Sales for Brazil and Rest of LatinAmerica Markets for Years 2006, 2014, & 2020 (includescorresponding Graph/Chart) III-96Table 117: Latin American Recent Past, Current & FutureAnalysis for Nuclear Medicine Imaging Equipment by ProductSegment - SPECT Systems and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-97Table 118: Latin American Historic Review for NuclearMedicine Imaging Equipment by Product Segment - SPECTSystems and PET Scanners Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2006 through2012 (includes corresponding Graph/Chart) III-98Table 119: Latin American 15-Year Perspective for NuclearMedicine Imaging Equipment by Product Segment - PercentageBreakdown of Value Sales for SPECT Systems and PET ScannersMarkets for Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-996a. BRAZIL III-100A.Market Analysis III-100Current & Future Analysis III-100B.Market Analytics III-100Table 120: Brazilian Recent Past, Current & Future Analysisfor Nuclear Medicine Imaging Equipment by Product Segment -SPECT Systems and PET Scanners Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Thousands forYears 2013 through 2020 (includes corresponding Graph/Chart) III-100Table 121: Brazilian Historic Review for Nuclear MedicineImaging Equipment by Product Segment - SPECT Systems and PETScanners Markets Independently Analyzed with Annual SalesFigures in US$ Thousands for Years 2006 through 2012(includes corresponding Graph/Chart) III-101Table 122: Brazilian 15-Year Perspective for NuclearMedicine Imaging Equipment by Product Segment - PercentageBreakdown of Value Sales for SPECT Systems and PET ScannersMarkets for Years 2006, 2014, & 2020 (includes correspondingGraph/Chart) III-1026b. REST OF LATIN AMERICA III-103A.Market Analysis III-103Current & Future Analysis III-103B.Market Analytics III-103Table 123: Rest of Latin America Recent Past, Current &Future Analysis for Nuclear Medicine Imaging Equipment byProduct Segment - SPECT Systems and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-103Table 124: Rest of Latin America Historic Review for NuclearMedicine Imaging Equipment by Product Segment - SPECTSystems and PET Scanners Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2006 through2012 (includes corresponding Graph/Chart) III-104Table 125: Rest of Latin America 15-Year Perspective forNuclear Medicine Imaging Equipment by Product Segment -Percentage Breakdown of Value Sales for SPECT Systems andPET Scanners Markets for Years 2006, 2014, & 2020 (includescorresponding Graph/Chart) III-1057. REST OF WORLD III-106A.Market Analysis III-106Current & Future Analysis III-106Strategic Corporate Development III-106B.Market Analytics III-107Table 126: Rest of World Recent Past, Current & FutureAnalysis for Nuclear Medicine Imaging Equipment by ProductSegment - SPECT Systems and PET Scanners MarketsIndependently Analyzed with Annual Sales Figures in US$Thousands for Years 2013 through 2020 (includescorresponding Graph/Chart) III-107Table 127: Rest of World Historic Review for NuclearMedicine Imaging Equipment by Product Segment - SPECTSystems and PET Scanners Markets Independently Analyzed withAnnual Sales Figures in US$ Thousands for Years 2006 through2012 (includes corresponding Graph/Chart) III-10Read the full report: http://www.reportlinker.com/p02365016-summary/view-report.htmlAbout Reportlinker ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com
__________________________Contact Clare: [email protected]
US: (339)-368-6001Intl: +1 339-368-6001
SOURCE Reportlinker
SOURCE Reportlinker
